Locoregional recurrence negatively impacts both long‐term survival and quality of life for
several malignancies. For appropriate‐risk patients with an isolated, resectable, local …

Despite the recent advances in drug development, the majority of novel therapeutics have
not been successfully translated into clinical applications. One of the major factors hindering …

In 2008, we published the first set of guidelines for standardizing research in autophagy.
Since then, this topic has received increasing attention, and many scientists have entered …

Tumours growing in a sheet-like manner on the surface of organs and tissues with complex
topologies represent a difficult-to-treat clinical scenario. Their complete surgical resection is …

Intraperitoneal co-delivery of chemotherapeutic drugs (CDs) and immune checkpoint
inhibitors (ICIs) brings hope to improve treatment outcomes in patients with peritoneal …

Local drug delivery systems, especially hydrogels, show superior strengths in postoperative
recurrence prevention. Despite great advances, clinical translation of the hydrogels has …

Nanoparticle biodistribution in vivo is an essential component to the success of nanoparticle-
based drug delivery systems. Previous studies with fluorescently labeled expansile …

A current challenge in the treatment of peritoneal carcinomatosis is the inability to detect,
visualize, and resect small or microscopic tumors of pancreatic, ovarian, or mesothelial …

Nanoparticles as drug-delivery systems have received significant attention due to their
merits such as prolonged circulation time and passive targeting of a tumor site. Polymer …

Nanoparticle (NP)‐based drug‐delivery systems are frequently employed to improve the
intravenous administration of chemotherapy; however, few reports explore their application …